Lab Tests for Peptide Stacks: BPC-157, TB-500, and the Wolverine Stack

Peptide protocols have moved from elite athletic circles into mainstream fitness and biohacking communities. BPC-157, TB-500, and stacked combinations like the "Wolverine Stack" are now widely used for injury recovery, tissue repair, and systemic inflammation reduction.

But because these compounds are not FDA-approved for human use, there are no official monitoring guidelines. That leaves most users flying blind — with no baseline to compare against and no way to know if something is going wrong.

This guide covers the blood tests that functional medicine practitioners and informed users recommend before and during a peptide protocol.

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice. In animal studies, it has shown remarkable regenerative properties — accelerating healing of tendons, ligaments, muscles, and gut tissue, and reducing inflammation.

TB-500 (Thymosin Beta-4) is a synthetic version of a naturally occurring peptide involved in cell migration, tissue repair, and angiogenesis (the formation of new blood vessels). It is widely used in equine medicine and has gained popularity among athletes for its recovery-promoting effects.

The Wolverine Stack combines BPC-157 and TB-500 together, with the goal of synergistic tissue repair — BPC-157 targeting localized healing and TB-500 providing systemic recovery support.

There are no blood tests that directly measure BPC-157 or TB-500 levels. These compounds are not detectable through standard panels. So why test at all?

Two reasons:

1. Baseline documentation: You need to know where your organ function and inflammation markers stand before you start. If something changes during your protocol, you will have data to compare against.
2. Safety monitoring: Even compounds with favorable safety profiles in animal studies can have unexpected effects in individual humans. Tracking liver enzymes, kidney function, and inflammatory markers gives you an early warning system.

This is the most important baseline test for any peptide protocol. The CMP checks:

• Liver enzymes (ALT, AST): BPC-157 has shown hepatoprotective effects in animal models, but you want a pre-protocol baseline to confirm your liver is healthy going in and to track any changes.
• Kidney function (BUN, Creatinine): Establishes a baseline for renal health.
• Electrolytes and glucose: General metabolic health markers.

Order it here: Comprehensive Metabolic Profile

This is the key marker for users running a recovery or anti-inflammatory protocol. hs-CRP measures systemic inflammation in your body. If BPC-157 and TB-500 are doing what proponents claim, you would expect this number to trend downward over the course of your protocol.

Baseline hs-CRP gives you a concrete, measurable starting point. Follow-up testing 8–12 weeks in tells you whether the protocol is having a real anti-inflammatory effect — or not.

Order it here: C-Reactive Protein

A CBC evaluates your red blood cells, white blood cells, and platelets. It rules out:

• Hidden infections that could complicate a recovery protocol
• Immune abnormalities
• Anemia, which would impair tissue healing regardless of what peptides you are using

It is also a useful general health snapshot to have on file before starting any new compound.

Order it here: Complete Blood Count

The Wolverine Stack — BPC-157 plus TB-500 — is typically run for 8–12 weeks. Here is the testing approach most functional medicine practitioners recommend:

Run all three baseline tests above:

• CMP — liver and kidney baseline
• hs-CRP — inflammation baseline
• CBC — general health and immune status

If you are experiencing unexpected symptoms — unusual fatigue, changes in urine color, GI distress — a repeat CMP is worth running to check liver and kidney function.

• CMP — confirm liver and kidney values are unchanged from baseline
• hs-CRP — compare to your pre-protocol number to assess anti-inflammatory effect
• CBC — confirm no immune or blood cell changes

These compounds are not approved for human use. BPC-157 and TB-500 are sold as research chemicals. Human clinical trial data is sparse, and long-term safety data does not exist. Lab testing provides a safety net — it does not make an unapproved compound safe.

There is no standardized monitoring protocol. The testing approach above is based on functional medicine practitioner recommendations and general safety principles, not official guidelines. Your individual situation may warrant additional testing.

Injection site hygiene matters. If you are self-injecting, a CBC can help identify early signs of infection that might otherwise go unnoticed.

You do not need a prescription to order a CMP, hs-CRP, or CBC. At Reliable Exams, you can order all three directly — no doctor's visit, no insurance required. Results are available within 1–2 business days from a LabCorp or Quest Diagnostics near you.

Browse our full test catalog at reliableexams.com/tests.

This article is for informational purposes only and does not constitute medical advice. BPC-157 and TB-500 are not approved by the FDA for human use. Consult a qualified healthcare provider before beginning any peptide protocol.